Newsletter
Every new paper in this field, in your inbox.
In an international multicenter study, early recurrence in resected intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic cancer was identified at 10.5 months. Among 381 patients, 42% experienced recurrence, with 38% classified as early recurrences. Key predictors included CA19-9 levels and N2 disease staging. The study stratified…
In patients with intermediate-stage hepatocellular carcinoma (HKLC stage IIB), preoperative transarterial chemoembolization (TACE) significantly improves survival outcomes compared to upfront surgery alone. A study involving 154 matched patients found that the median overall survival for the TACE group undergoing surgical resection was 90.97 months, versus…
A study involving 208 locally advanced pancreatic cancer (LAPC) patients found that those undergoing radical resection combined with intestinal autotransplantation (RRCIA) after systemic treatment significantly improved overall survival (OS) and progression-free survival (PFS). Specifically, the RRCIA group showed a median OS of 25.8 months compared…
Evaluating lymph nodes during surgery for perihilar cholangiocarcinoma can significantly enhance patient outcomes. In a study of 341 patients, those undergoing lymphadenectomy of stations 12, 8, and 13 demonstrated improved overall survival compared to those receiving only station 12 (HR 0.51). The highest therapeutic index…
Preoperative robotic median arcuate ligament release significantly mitigates complications in pancreatoduodenectomy, particularly for patients with celiac artery stenosis. The technique demonstrates a nearly 90% success rate in resolving ischemic complications, preventing hepatic ischemia, and ensuring normal arterial flow to the gastrointestinal tract. A case involving…
In a study of 191 endoscopic ultrasonography (EUS)-guided biliary drainage procedures, researchers achieved a technical success rate of 97.38% and a clinical success rate of 89.01%. Among the 191 patients, 16.75% experienced complications, including six fatal cases. These advanced techniques offer effective alternatives to traditional…
Researchers identified a pancreatic juice-specific fluorescent probe, selectively targeting ectonucleotide pyrophosphatase/phosphodiesterase (enpp) 1, from a library of 411 enzyme-activatable fluorescent probes. The probe demonstrated high reactivity with pancreatic juice, providing the potential for visualizing pancreatic juice leakage during surgery. This advancement may assist surgeons in…
A cohort analysis of 1,130 patients with postoperative pancreatic fistulas (popf) found that those undergoing minimally invasive pancreatoduodenectomy (mipd) faced a significantly higher risk of additional complications compared to traditional open procedures (opd). Notably, 55% of mipd-popf patients encountered a secondary complication, including a higher…
Expert consensus has identified 82 best practices for delivering neoadjuvant therapy (NT) in localized pancreatic ductal adenocarcinoma (PDAC). Key areas include pre-NT evaluations, effective initiation and management during NT, and post-NT surgical and follow-up strategies. With 47 North American specialists involved, the findings aim to…
A study analyzing 1,001 pancreas ductal adenocarcinoma patients found that those from less marginalized backgrounds, indicated by the Area Deprivation Index (ADI), were 1.57 times more likely to attend follow-up appointments post-surgery compared to marginalized individuals. The study highlights significant disparities in patient follow-up rates,…
